This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Aetiology

Authoring team

Causes of olecranon bursitis can generally be classified as (1):

  • septic
    • seen in one third of presenting cases o usually caused when micro-organisms enter the bursa through soft tissue due to trauma, breaks in the skin or foci of infection (2)
    • occasionally penetration through minute skin breaks could be considered in patients who lack a history of trauma or visible injury (2)
    • 80-90% cases are due to S. aureus (1,2)
    • the following are at risk of developing septic bursitis -
      • people with a history of previous episodes of olecranon bursitis
      • impaired immunity caused by steroids, diabetes, renal impairment, alcohol abuse (2)
  • non-septic
    • usually caused by acute trauma, overuse, crystal deposition (e.g. gout), or systemic disease (1)
    • majority occurs in males who are in the age group between 50 to 70 years (3)

People undergoing chronic dialysis are suggested to be at an increased risk of developing olecranon bursitis. Several contributory factors have been put forward:

  • persistent pressure on the olecranon bursa through the haemodylasis session
  • accumulation of oxalate in the synovium and the skin are thought to contribute to bursitis (3)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.